Literature DB >> 14726086

Thrombosis of aortic valve homograft associated with lupus anticoagulant antibodies.

Philippe Unger1, Danièle Plein, Olivier Pradier, Jean-Louis LeClerc.   

Abstract

One of the main advantages of an aortic valve homograft in comparison with a mechanical prosthesis is the low incidence of thromboembolism without anticoagulation. Development of an obstructive thrombosis is virtually unknown. We report the case of a patient who twice was seen with hemodynamically significant thrombosis of an aortic valve homograft. The diagnosis was suspected on the basis of a subacute increase in the transvalvular gradient and was confirmed by transesophageal echocardiography. Lupus anticoagulant antibodies were detected. Oral anticoagulation proved to be effective in relieving the obstruction, but recurrence after discontinuation of acenocoumeral suggests that treatment should be long term, if not lifelong. To our knowledge, this complication of primary antiphospholipid syndrome is the first reported case of thrombotic obstruction of an aortic valve homograft.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726086     DOI: 10.1016/s0003-4975(03)01039-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Aortic valve replacement for aortic regurgitation in a patient with antiphospholipid antibody syndrome.

Authors:  Nozomu Sasahashi; Hisao Harada; Yoshiaki Saji; Akira Marui; Takeshi Nishina; Masashi Komeda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-07

Review 2.  Current treatment of antiphospholipid syndrome: lights and shadows.

Authors:  Gerard Espinosa; Ricard Cervera
Journal:  Nat Rev Rheumatol       Date:  2015-06-30       Impact factor: 20.543

Review 3.  Valvular heart disease in antiphospholipid syndrome.

Authors:  Stéphane Zuily; Olivier Huttin; Shirine Mohamed; Pierre-Yves Marie; Christine Selton-Suty; Denis Wahl
Journal:  Curr Rheumatol Rep       Date:  2013-04       Impact factor: 4.592

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.